Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Detection of intracellular Factor VIII protein in peripheral blood mononuclear cells by flow cytometry.

Pandey GS, Tseng SC, Howard TE, Sauna ZE.

Biomed Res Int. 2013;2013:793502. doi: 10.1155/2013/793502. Epub 2013 Feb 28.

2.

Blockade of CD40/CD40 ligand interactions prevents induction of factor VIII inhibitors in hemophilic mice but does not induce lasting immune tolerance.

Reipert BM, Sasgary M, Ahmad RU, Auer W, Turecek PL, Schwarz HP.

Thromb Haemost. 2001 Dec;86(6):1345-52.

PMID:
11776297
3.

Chemical chaperones improve protein secretion and rescue mutant factor VIII in mice with hemophilia A.

Roth SD, Schüttrumpf J, Milanov P, Abriss D, Ungerer C, Quade-Lyssy P, Simpson JC, Pepperkok R, Seifried E, Tonn T.

PLoS One. 2012;7(9):e44505. doi: 10.1371/journal.pone.0044505. Epub 2012 Sep 4.

4.

Expression of human coagulation factor VIII in a human hybrid cell line, HKB11.

Mei B, Chen Y, Chen J, Pan CQ, Murphy JE.

Mol Biotechnol. 2006 Oct;34(2):165-78.

PMID:
17172662
5.

Recombinant factor VIII and factor VIII-von Willebrand factor complex do not present danger signals for human dendritic cells.

Pfistershammer K, Stöckl J, Siekmann J, Turecek PL, Schwarz HP, Reipert BM.

Thromb Haemost. 2006 Sep;96(3):309-16.

PMID:
16953272
6.

Anti-CD3 antibodies modulate anti-factor VIII immune responses in hemophilia A mice after factor VIII plasmid-mediated gene therapy.

Peng B, Ye P, Rawlings DJ, Ochs HD, Miao CH.

Blood. 2009 Nov 12;114(20):4373-82. doi: 10.1182/blood-2009-05-217315. Epub 2009 Sep 21.

7.

Preparation of factor-VIII-depleted plasma with antibodies and its use for the assay of factor VIII.

Rothschild C, Amiral J, Adam M, Meyer D.

Haemostasis. 1990;20(6):321-8.

PMID:
2129163
8.

Single cell analysis of factor VIII-specific T cells in hemophilic mice after treatment with human factor VIII.

Sasgary M, Ahmad RU, Schwarz HP, Turecek PL, Reipert BM.

Thromb Haemost. 2002 Feb;87(2):266-72.

PMID:
11858486
9.

Adenovirus-mediated factor VIII gene expression results in attenuated anti-factor VIII-specific immunity in hemophilia A mice compared with factor VIII protein infusion.

Bristol JA, Gallo-Penn A, Andrews J, Idamakanti N, Kaleko M, Connelly S.

Hum Gene Ther. 2001 Sep 1;12(13):1651-61.

PMID:
11535168
10.

Development and characterization of recombinant ovine coagulation factor VIII.

Zakas PM, Gangadharan B, Almeida-Porada G, Porada CD, Spencer HT, Doering CB.

PLoS One. 2012;7(11):e49481. doi: 10.1371/journal.pone.0049481. Epub 2012 Nov 9.

11.

Enhanced uptake of blood coagulation factor VIII containing immune complexes by antigen presenting cells.

Hartholt RB, Wroblewska A, Herczenik E, Peyron I, Ten Brinke A, Rispens T, Nolte MA, Slot E, Claassens JW, Nimmerjahn F, Verbeek JS, Voorberg J.

J Thromb Haemost. 2017 Feb;15(2):329-340. doi: 10.1111/jth.13570. Epub 2017 Jan 19.

12.

Hematopoietic stem cells encoding porcine factor VIII induce pro-coagulant activity in hemophilia A mice with pre-existing factor VIII immunity.

Doering CB, Gangadharan B, Dukart HZ, Spencer HT.

Mol Ther. 2007 Jun;15(6):1093-9. Epub 2007 Mar 27.

13.
14.

Frequency and epitope specificity of anti-factor VIII C1 domain antibodies in acquired and congenital hemophilia A.

Kahle J, Orlowski A, Stichel D, Healey JF, Parker ET, Jacquemin M, Krause M, Tiede A, Schwabe D, Lollar P, Königs C.

Blood. 2017 Aug 10;130(6):808-816. doi: 10.1182/blood-2016-11-751347. Epub 2017 May 15.

15.

Induction of factor VIII-specific unresponsiveness by intrathymic factor VIII injection in murine hemophilia A.

Madoiwa S, Yamauchi T, Kobayashi E, Hakamata Y, Dokai M, Makino N, Kashiwakura Y, Ishiwata A, Ohmori T, Mimuro J, Sakata Y.

J Thromb Haemost. 2009 May;7(5):811-24. doi: 10.1111/j.1538-7836.2009.03314.x. Epub 2009 Feb 12.

16.

Factor VIII bypasses CD91/LRP for endocytosis by dendritic cells leading to T-cell activation.

Dasgupta S, Navarrete AM, André S, Wootla B, Delignat S, Repessé Y, Bayry J, Nicoletti A, Saenko EL, d'Oiron R, Jacquemin M, Saint-Remy JM, Kaveri SV, Lacroix-Desmazes S.

Haematologica. 2008 Jan;93(1):83-9. doi: 10.3324/haematol.11535.

17.

Expression and characterization of recombinant murine factor VIII.

Doering C, Parker ET, Healey JF, Craddock HN, Barrow RT, Lollar P.

Thromb Haemost. 2002 Sep;88(3):450-8.

PMID:
12353075
18.

A subset of high-titer anti-factor VIII A2 domain antibodies is responsive to treatment with factor VIII.

Eubanks J, Baldwin WH, Markovitz R, Parker ET, Cox C, Kempton CL, Meeks SL.

Blood. 2016 Apr 21;127(16):2028-34. doi: 10.1182/blood-2015-09-670034. Epub 2016 Jan 29.

20.

Characterization of human hybridoma clones isolated from hemophilia patients with specificity for different domains of coagulating factor VIII.

Gharagozlou S, Ghods R, Bahrami ZS, Roohi A, Jeddi-Tehrani M, Conti-Fine BM, Sharifian RA, Rabbani H, Shokri F.

Hum Antibodies. 2003;12(3):67-76.

PMID:
14646035

Supplemental Content

Support Center